Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate
A combination of PEG-3350, electrolytes, and ascorbate used as an osmotic laxative to clean the colon before a colonoscopy in adults.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 3 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
This is a prescription bowel prep used once before a colonoscopy, an osmotic laxative that pulls water into the colon and holds it there to flush it clean; on the U.S. market since about 2006 and available as a generic, it is one of the common lower-volume prep choices. It reliably works, and heavy watery diarrhea is the point, but nausea, bloating, cramping and thirst are common too. The real risk is a shift in your body’s salt and mineral levels, which can rarely trigger an irregular heartbeat, seizures or kidney injury, so drink all the extra clear liquid and tell your doctor beforehand about any heart, kidney or seizure history.
Clinical pearls
- Take your other oral medicines at least 1 hour before each dose, or the prep may keep them from being absorbed.
- Do not add a stimulant laxative such as bisacodyl alongside it, since that combination raises the risk of colon ulcers.
- Ibuprofen and other NSAIDs raise the kidney risk during the prep, especially if you get dehydrated.
- It contains phenylalanine and ascorbate, which matter for anyone with PKU or G6PD deficiency (an inherited red blood cell enzyme problem).
Patient information guide A plain-language walkthrough of Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate, written from its FDA label.
What Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate is used for
▾
This ingredient combination is the active basis for several prescription colonoscopy prep products, each indicated for the same purpose in adults.
- MoviPrep is indicated to cleanse the colon as a preparation for colonoscopy in adults
- PLENVU is indicated to cleanse the colon as a preparation for colonoscopy in adults
- Polyethylene Glycol-3350, Electrolytes, and Ascorbate for Oral Solution (generic) is indicated to cleanse the colon as a preparation for colonoscopy in adults
How Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate works
▾
These ingredients work together through an osmotic effect — they are not well absorbed in the gut, so they draw large amounts of water into the colon and hold it there. The resulting surge of fluid produces a strong, watery diarrhea that flushes the bowel clean. PEG-3350, sodium sulfate, sodium ascorbate, and ascorbic acid all contribute to this osmotic pull. Most people experience their first bowel movement within about 1 to 2 hours of starting the preparation.
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate dosage
▾
These preparations are taken as a reconstituted oral liquid — you mix powder pouches with water before drinking. Two separate doses are always needed for a complete bowel prep. Your prescriber will choose from two dosing schedules:
- Split-dose (Two-Day): First dose the evening before the colonoscopy, second dose the morning of the colonoscopy (roughly 12 hours apart) — this is the preferred method for MoviPrep and the generic, and a standard option for PLENVU
- Same-evening (One-Day Evening-Only): Both doses taken the evening before the colonoscopy, at least 90 minutes apart — an alternative method for MoviPrep and the generic
- One-Day Morning (PLENVU): Both doses taken the morning of the colonoscopy, with at least 2 hours between the start of dose 1 and the start of dose 2
Drink additional clear liquids after each dose, eat only clear liquids from the start of prep until after the colonoscopy, and take all other oral medications at least 1 hour before each dose. Follow your prescriber's specific instructions closely.
Dosing details from the FDA-approved label
From the Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Plenvu – Two-Day Split Dosage regimen (colonoscopy preparation)
- Dose 1 the evening before the colonoscopy (approximately 4 pm to 8 pm) and Dose 2 the next morning (approximately 12 hours after the start of Dose 1
- Between approximately 4 am and 8 am)
- Dose 1: empty contents into mixing container, add water to the fill line (at least 16 fluid ounces), drink over the next 30 minutes, then refill to the fill line (at least
- Complete Dose 2 including all additional liquids at least 2 hours before the colonoscopy; delay Dose 2 if severe bloating, abdominal distention or abdominal pain follows Dose 1
- Plenvu – One-Day Morning Dosage regimen (colonoscopy preparation)
- Dose 1 the morning of the colonoscopy (approximately 3 am to 7 am) and Dose 2 a minimum of 2 hours after the start of Dose 1. Dose 1: empty contents into mixing container, add water to the fill line (at least 16 fluid ounces), drink over the next 30 minutes, then refill to the fill line (at least 16 fluid ounces) with clear liquids and drink over the next 30
- Light breakfast and light lunch the day before, and clear broth soup and/or plain yogurt for dinner, completed by approximately 8 pm
- MoviPrep – Two-Day (Split-Dose) regimen, preferred method (colonoscopy preparation)
- Dose 1 the evening before the colonoscopy, and Dose 2 the morning of the colonoscopy (approximately 12 hours after the start of Dose 1, and at least 3 ½ hours prior to the colonoscopy)
- Do not take oral medications within 1 hour of starting each dose
- MoviPrep – One-Day (Evening Only) regimen, alternative method (colonoscopy preparation)
- Dose 1 at least 3 ½ hours prior to bedtime the evening before the colonoscopy and Dose 2 approximately 1 ½ hours after starting Dose 1 the evening before the colonoscopy
- Minimum of 1.5 hours between the start of the first dose and the start of the second dose
Read the label’s full dosing text
2 DOSAGE AND ADMINISTRATION Preparation and Administration: • Two doses of Polyethylene Glycol-3350, Electrolytes, and Ascorbate for Oral Solution are required for a complete preparation for colonoscopy, using a “Two-Day” preferred method or “One-Day” alternative method dosing regimen. ( 2.1 ) • Polyethylene Glycol-3350, Electrolytes, and Ascorbate for Oral Solution must be reconstituted in water prior to ingestion. ( 2.1 ) • Additional clear liquids must be consumed after each dose of Polyethylene Glycol-3350, Electrolytes, and Ascorbate for Oral Solution in both dosing regimens. ( 2.1 , 5.1 ) • Do not take other laxatives while taking Polyethylene Glycol-3350, Electrolytes, and Ascorbate for Oral Solution. ( 2.1 , 5.5 ) • Do not take oral medications within 1 hour of starting each dose. ( 2.1 ) Dosing Regimen: • Two-Day (Split-Dose) (Preferred Method): Dose 1 the evening before the colonoscopy, and Dose 2 the morning of the colonoscopy (approximately 12 hours after the start of Dose 1, and at least 3 ½ hours prior to the colonoscopy). ( 2.2 ) • One-Day (Evening Only) (Alternative Method) : Dose 1 at least 3 ½ hours prior to bedtime the evening before the colonoscopy and Dose 2 approximately 1 ½ hours after starting Dose 1 the evening before the colonoscopy. ( 2.3 ) • For complete information on dosing, preparation and administration see full prescribing information ( 2.1 , 2.2 , 2.3 ) 2.1 Important Preparation and Administration Instructions • Correct fluid and electrolyte abnormalities before treatment with Polyethylene Glycol-3350, Electrolytes, and Ascorbate for Oral Solution [see Warnings and Precautions ( 5.1 )]. • Two doses of Polyethylene Glycol-3350, Electrolytes, and Ascorbate for Oral Solution are required for a complete preparation for colonoscopy. The time interval between the two doses depends on the regimen prescribed and the planned timing of the colonoscopy procedure. [see Dosage and Administration ( 2.2 , 2.3 ) ] . • The “Split-Dose” is the preferred method and consists of two separate doses: the first dose is taken the evening before the colonoscopy, and the second dose is taken the next day, the morning of the day of the colonoscopy [see Dosage and Administration ( 2.2 )].
Excerpted — the section continues on the label. Read the full Dosage and Administration section on DailyMed →
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate side effects
▾
Most people experience some gastrointestinal discomfort — that's a normal part of how this preparation works.
Common side effects
- Nausea
- Abdominal pain or cramping
- Vomiting
- Bloating or abdominal distension
- Malaise (feeling generally unwell)
- Anal discomfort
- Thirst
- Dizziness
- Sleep disturbance
When to get medical help
- Get emergency help if you have signs of a severe allergic reaction: swelling of the lips, tongue, or face; difficulty breathing; chest tightness; or hives
- Call your doctor if you have significant vomiting or signs of dehydration after taking the preparation
- Seek care right away for irregular or rapid heartbeat — rare but serious heart rhythm problems have been reported
- Call your doctor if you have a seizure or lose consciousness
- Tell your care team right away if you notice signs of kidney problems such as a major drop in urine output
Diarrhea is expected and is how the preparation does its job. More serious reactions — including severe allergic reactions, irregular heartbeat, seizures, or signs of kidney injury — are rare but require immediate medical attention.
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate warnings and precautions
▾
- Fluid and electrolyte imbalances are the most important risk. Losing too much fluid or having shifts in sodium, potassium, or other minerals can trigger serious heart rhythm problems, seizures, or kidney injury. Drink plenty of fluids and call your doctor if you vomit heavily or feel severely dehydrated.
- Cardiac arrhythmias (irregular heartbeat) have been reported rarely, mainly in people with existing heart conditions or electrolyte problems. Your doctor may order an ECG (heart tracing) before and after the procedure if you are at higher risk.
- Seizures have occurred rarely, linked to electrolyte imbalances. Extra caution is needed if you have a seizure history or take medications that lower the seizure threshold.
- Kidney injury is possible, especially if you have existing kidney disease or take medications that affect kidney function. Stay well hydrated.
- Severe allergic reactions (anaphylaxis), including swelling, trouble breathing, and rash, have been reported. Seek emergency care immediately if these occur.
- Aspiration risk: People with swallowing problems should be monitored while taking the liquid. Never mix with starch-based thickeners — doing so can thin the liquid and increase choking risk.
- Contains phenylalanine — people with phenylketonuria (PKU) must discuss this with their doctor before using.
- Use with extra caution if you have G6PD deficiency, as the ascorbate component may trigger hemolysis (breakdown of red blood cells).
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate interactions
▾
Several medications and substances can interact with this bowel preparation by increasing the risk of electrolyte problems, kidney injury, or other complications.
- Diuretics (water pills): Already affect fluid and electrolyte balance; combining with this prep raises the risk of imbalances further
- ACE inhibitors and ARBs (blood pressure medications): Can worsen kidney stress and electrolyte shifts during the prep
- NSAIDs (like ibuprofen or naproxen): May increase the risk of kidney injury, especially with dehydration
- Tricyclic antidepressants and other medications that lower the seizure threshold: Raise seizure risk when electrolytes are disturbed
- All oral medications: This preparation can reduce how well your body absorbs other drugs — take all oral medications at least 1 hour before starting each dose
- Stimulant laxatives (bisacodyl, sodium picosulfate): Do not use at the same time — increases risk of ulceration or ischemic colitis in the colon
- Starch-based thickeners: Never mix these into the solution — PEG thins starch-thickened liquids and can cause choking or aspiration
Interactions listed in the FDA-approved label
From the Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
- Drugs or conditions that increase the risk for fluid and electrolyte disturbances (or risk of renal impairment, seizures, arrhythmias, or QT prolongation): These may increase risks due to fluid and electrolyte abnormalities. Use caution when prescribing; consider additional patient evaluations as appropriate.
- Other oral medications: Polyethylene Glycol-3350, Electrolytes, and Ascorbate for Oral Solution can reduce the absorption of other co-administered drugs. Administer oral medications at least 1 hour before the start of each dose.
- Stimulant laxatives (e.g., bisacodyl, sodium picosulfate): Concurrent use may increase the risk of mucosal ulceration or ischemic colitis. Avoid use of stimulant laxatives while taking the product.
Read the label’s full interactions text
7 DRUG INTERACTIONS Drugs that increase risk for fluid and electrolyte imbalance. ( 7.1 ) 7.1 Drugs That May Increase Risks due to Fluid and Electrolyte Abnormalities Use caution when prescribing Polyethylene Glycol-3350, Electrolytes, and Ascorbate for Oral Solution for patients with conditions and/or who are using medications that increase the risk for fluid and electrolyte disturbances or may increase the risk of renal impairment, seizures, arrhythmias, or QT prolongation in the setting of fluid and electrolyte abnormalities [see Warnings and Precautions ( 5.1 , 5.2 , 5.3 , 5.4 )]. Consider additional patient evaluations as appropriate. 7.2 Potential for Reduced Drug Absorption Polyethylene Glycol-3350, Electrolytes, and Ascorbate for Oral Solution can reduce the absorption of other co-administered drugs. Administer oral medications at least 1 hour before the start of administration of each dose of Polyethylene Glycol-3350, Electrolytes, and Ascorbate for Oral Solution [see Dosage and Administration ( 2.1 )] . 7.3 Stimulant Laxatives Concurrent use of stimulant laxatives and Polyethylene Glycol-3350, Electrolytes, and Ascorbate for Oral Solution may increase the risk of mucosal ulceration or ischemic colitis. Avoid use of stimulant laxatives (e.g., bisacodyl, sodium picosulfate) while taking Polyethylene Glycol-3350, Electrolytes, and Ascorbate for Oral Solution [see Warnings and Precautions ( 5.5 , 5.6 )].
7.1 Drugs That May Increase Risks due to Fluid and Electrolyte Abnormalities Use caution when prescribing Polyethylene Glycol-3350, Electrolytes, and Ascorbate for Oral Solution for patients with conditions and/or who are using medications that increase the risk for fluid and electrolyte disturbances or may increase the risk of renal impairment, seizures, arrhythmias, or QT prolongation in the setting of fluid and electrolyte abnormalities [see Warnings and Precautions ( 5.1 , 5.2 , 5.3 , 5.4 )]. Consider additional patient evaluations as appropriate.
Excerpted — the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate
▾
- Do not use if you have a bowel blockage (GI obstruction), bowel perforation, gastric retention, ileus, or toxic colitis or toxic megacolon — these are contraindications
- Tell your doctor about any allergy to any ingredient, including polyethylene glycol or lemon flavoring components
- Tell your doctor if you have kidney disease or take medications that affect kidney function
- Tell your doctor if you have heart disease, irregular heartbeat, heart failure, recent heart attack, or unstable angina
- Tell your doctor if you have a history of seizures or take medications that lower the seizure threshold
- Tell your doctor if you have G6PD deficiency — the ascorbate content may trigger hemolysis
- Tell your doctor if you have phenylketonuria (PKU) — this preparation contains phenylalanine
- Tell your doctor if you have severe ulcerative colitis or suspected inflammatory bowel disease
- If you have trouble swallowing or an impaired gag reflex, tell your care team — you should be monitored during administration
- Pregnancy: There are no adequate human data on safety; discuss with your doctor
- Breastfeeding: Not enough data is available; discuss risks and benefits with your doctor
- Children: Safety and effectiveness have not been established in pediatric patients
- Older adults: Used safely in clinical trials, but elderly patients are more susceptible to fluid and electrolyte problems and should be monitored closely
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate overdose
▾
Taking more than the recommended amount can cause severe electrolyte disturbances — including dangerously low sodium (hyponatremia) or potassium (hypokalemia) — as well as dehydration and low blood volume. In serious cases, this can lead to heart rhythm problems, seizures, or kidney failure.
If overdose is suspected, seek medical attention and treatment will focus on monitoring and correcting fluid and electrolyte levels.
What Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate does in the body
▾
When swallowed, the unabsorbed PEG, ascorbate, and sulfate ions create a strong osmotic effect in the colon — pulling water into the bowel and keeping it there. This produces a large volume of watery diarrhea that flushes the colon clean. The first bowel movement typically occurs about 1 to 2 hours after starting PLENVU, and the effect is rapid and thorough by design.
How your body processes Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate
▾
Most of the PEG-3350 in these preparations stays in the gut and is excreted in the stool — studies show 85% to 99% of the PEG dose leaves the body in the feces. Similarly, the majority of ascorbate (about 69%) and sodium sulfate (69–73%) are eliminated in stool, with some ascorbate and sulfate also appearing in urine. PEG-3350 that is absorbed has a half-life (the time for the body to clear half of it) of about 4 hours; ascorbate has a half-life of about 7 hours; and sulfate about 10.5 hours. Because so little is absorbed into the bloodstream, these preparations act mainly within the digestive tract rather than throughout the body.
How to store Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate
▾
Store pack at room temperature, between 68°F to 77°F (20°C to 25°C) with excursions permitted to 59°F to 86°F (15°C to 30°C) . stored in a refrigerator.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly is this prep for — is it a laxative I'll take regularly?
▾
When will I actually start going to the bathroom after I take it?
▾
Do I need to fast completely, or can I eat something?
▾
What should I do with my regular daily medications while taking this prep?
▾
What side effects should I just expect versus ones that mean I need to call someone?
▾
I'm pregnant — is this prep safe to take?
▾
Is Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate available over the counter?
▾
When was Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate first available?
▾
Who makes Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate on HelloPharmacist
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate on the U.S. market: products, makers and brands
How Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
2 companies list 3 Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate product records with the FDA; the earliest marketing or approval year on record is 2006. Brand names on the directory include MoviPrep, Plenvu; the rest are generics.
Also listed with the FDA, not a patient dose form: Kit (9) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate is used (Medicaid data)
A general measure of how commonly Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate prescribed? Of the 1,601 medications we measure, Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate ranks #930 by Medicaid prescriptions — more than 42% of them.
Utilization by Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
ascorbic acid 4700 MG / polyethylene glycol 3350 100000 MG / potassium chloride 1015 MG / sodium ascorbate 5900 MG / sodium chloride 2690 MG / sodium sulfate 7500 MG Powder for Oral Solution
Summed across the 3 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 800915
Other Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate products — combination packs and listings not yet matched to a specific clinical product (kept visible so every prescription is accounted for)
Summed across the 1 of 2 listed NDC products with Medicaid activity.
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 4 of 7 listed Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate NDCs with Medicaid activity.
Compare Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate products
A representative set of FDA-listed product records for Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|
| 💊Kits | ||
| Oceanside Pharmaceuticals | NDA | View NDC → |
| Salix Pharmaceuticals, Inc | NDA | View NDC → |
| Salix Pharmaceuticals, Inc. | NDA | View NDC → |
Showing 3 of 3 products — FDA National Drug Code Directory. See every product, package size and price: browse all 3 Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate NDCs →
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate FDA approval history
How Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate recalls since July 2021.
✅No Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one exact multiple-ingredient concept (MIN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). A product with a different ingredient combination belongs on a different page.
RxCUI 1007544 1 dose form · 1 strength
-
Dose form (SCDF) Powder for Oral Solution RxCUI 1870185No current FDA listingClinical drug / strength (SCD) ascorbic acid 4700 MG / polyethylene glycol 3350 100000 MG / potassium chloride 1015 MG / sodium ascorbate 5900 MG / sodium chloride 2690 MG / sodium sulfate 7500 MGRxCUI 800915
Look up RxCUI 1007544 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate supply and shortage status
Whether Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate brand names
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate is sold under 2 brand names in the FDA directory — MoviPrep, Plenvu. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate: manufacturers and labelers
2 companies list Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate products with the FDA. By number of product records, the largest are Salix Pharmaceuticals, Inc, Oceanside Pharmaceuticals. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate drug class (RxNorm)
Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate belongs to the Vitamin C class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Ascorbic Acid / Polyethylene Glycol 3350 / Potassium Chloride / Sodium Ascorbate / Sodium Chloride / Sodium Sulfate page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Salix Pharmaceuticals, Inc is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →